Fig. 11From: The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing dataGene alteration frequency of UBE2C in BRCA tissues from different tissues. There was less than 5% frequency of UBE2C gene alteration in most BRCA tissues except BRCA tissues from BRCACRC xenografts. Among the BRCA cases with gene alteration of UBE2C, amplification occupied the overwhelming majority of alteration typesBack to article page